Bristol-Myers Squibb
BMY
$48.06
Share price
1.89%
Change (1 day)
11.38%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) Fails to deliver data
Key failure to deliver metrics for Bristol-Myers Squibb:
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: $0.19 M
- Last 3 months FTD volume: $11.54 M
- Last year FTD volume: $11.54 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Bristol-Myers Squibb (BMY) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Bristol-Myers Squibb (BMY) - since 2013
Volume in USD (price x number of shares), data since 2013Bristol-Myers Squibb (BMY) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | $41.32 M | -91.3% |
| 2024 | $0.47 B | 204.56% |
| 2023 | $0.15 B | -29.53% |
| 2022 | $0.22 B | 107.77% |
| 2021 | $0.10 B | -72.46% |
| 2020 | $0.38 B | -11.25% |
| 2019 | $0.43 B | 203.91% |
| 2018 | $0.14 B | -20.27% |
| 2017 | $0.17 B | 4.53% |
| 2016 | $0.17 B | -7.42% |
| 2015 | $0.18 B | 76.57% |
| 2014 | $0.10 B | 237.33% |
| 2013 | $31.21 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $26.37 M | $0.27 B | 🇺🇸 USA |
 Merck MRK | $12.12 M | $0.17 B | 🇺🇸 USA |
 Eli Lilly LLY | $37.29 M | $0.20 B | 🇺🇸 USA |
 Novartis NVS | $8.82 M | $0.15 B | 🇨🇭 Switzerland |
 Sanofi SNY | $46.75 M | $67.7 M | 🇫🇷 France |
 AstraZeneca AZN | $23.77 M | $0.14 B | 🇬🇧 UK |
 Johnson & Johnson JNJ | $10.58 M | $0.12 B | 🇺🇸 USA |
 AbbVie ABBV | $25.73 M | $0.20 B | 🇺🇸 USA |
 Amgen AMGN | $21.56 M | $0.29 B | 🇺🇸 USA |
 Biogen BIIB | $8.78 M | $62.76 M | 🇺🇸 USA |